{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:39Z","timestamp":1793500539041,"version":"4.5.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The liver is a major metastatic site (organ) for gastrointestinal cancers (such as colorectal, gastric, and pancreatic cancers) as well as non-gastrointestinal cancers (such as lung, breast, and melanoma cancers). Due to the innate anatomical position of the liver, the apoptosis of T cells in the liver, the unique metabolic regulation of hepatocytes and other potential mechanisms, the liver tends to form an immunosuppressive microenvironment and subsequently form a pre-metastatic niche (PMN), which can promote metastasis and colonization by various tumor cells(TCs). As a result, the critical role of immunoresponse in liver based metastasis has become increasingly appreciated. T cells, a centrally important member of adaptive immune response, play a significant role in liver based metastases and clarifying the different roles of the various T cells subsets is important to guide future clinical treatment. In this review, we first introduce the predisposing factors and related mechanisms of liver metastasis (LM) before introducing the PMN and its transition to LM. Finally, we detail the role of different subsets of T cells in LM and advances in the management of LM in order to identify potential therapeutic targets for patients with LM.<\/jats:p>","DOI":"10.1038\/s41419-024-06726-2","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T02:02:15Z","timestamp":1715824935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Role of T cells in liver metastasis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0460-6889","authenticated-orcid":false,"given":"Kejia","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6990-8621","authenticated-orcid":false,"given":"Wei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5513-5977","authenticated-orcid":false,"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-717X","authenticated-orcid":false,"given":"Yunjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"6726_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, et al. Exosome-derived circCCAR1 promotes CD8+ T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023;22:55.","journal-title":"Mol Cancer"},{"key":"6726_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"6726_CR3","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1158\/1078-0432.CCR-15-1636","volume":"23","author":"S Milette","year":"2017","unstructured":"Milette S, Sicklick JK, Lowy AM, Brodt P. Molecular pathways: targeting the microenvironment of liver metastases. Clin Cancer Res. 2017;23:6390\u20139.","journal-title":"Clin Cancer Res"},{"key":"6726_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med. 2021;27:152\u201364.","journal-title":"Nat Med"},{"key":"6726_CR5","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/cncr.21778","volume":"106","author":"KR Hess","year":"2006","unstructured":"Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106:1624\u201333.","journal-title":"Cancer"},{"key":"6726_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s10585-011-9419-3","volume":"28","author":"P Thomas","year":"2011","unstructured":"Thomas P, Forse RA, Bajenova O. Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver. Clin Exp Metastasis. 2011;28:923\u201332.","journal-title":"Clin Exp Metastasis"},{"key":"6726_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"6726_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/cmi.2013.7","volume":"10","author":"F Li","year":"2013","unstructured":"Li F, Tian Z. The liver works as a school to educate regulatory immune cells. Cell Mol Immunol. 2013;10:292\u2013302.","journal-title":"Cell Mol Immunol"},{"key":"6726_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00281-022-00917-9","volume":"44","author":"N Taniki","year":"2022","unstructured":"Taniki N, Nakamoto N, Chu PS, Ichikawa M, Teratani T, Kanai T. Th17 cells in the liver: balancing autoimmunity and pathogen defense. Semin Immunopathol. 2022;44:509\u201326.","journal-title":"Semin Immunopathol"},{"key":"6726_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12272-019-01146-9","volume":"42","author":"SH Chang","year":"2019","unstructured":"Chang SH. T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer. Arch Pharmacal Res. 2019;42:549\u201359.","journal-title":"Arch Pharmacal Res"},{"key":"6726_CR11","first-page":"98","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8:98\u2013101.","journal-title":"Cancer Metastasis Rev"},{"key":"6726_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm1469","volume":"12","author":"PS Steeg","year":"2006","unstructured":"Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12:895\u2013904.","journal-title":"Nat Med"},{"key":"6726_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri981","volume":"3","author":"IN Crispe","year":"2003","unstructured":"Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol. 2003;3:51\u201362.","journal-title":"Nat Rev Immunol"},{"key":"6726_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","volume":"66","author":"DG Doherty","year":"2016","unstructured":"Doherty DG. Immunity, tolerance and autoimmunity in the liver: a comprehensive review. J Autoimmun. 2016;66:60\u201375.","journal-title":"J Autoimmun"},{"key":"6726_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1046\/j.0818-9641.2001.01048.x","volume":"80","author":"P Bertolino","year":"2002","unstructured":"Bertolino P, McCaughan GW, Bowen DG. Role of primary intrahepatic T-cell activation in the \u2018liver tolerance effect. Immunol Cell Biol. 2002;80:84\u201392.","journal-title":"Immunol Cell Biol"},{"key":"6726_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/223472a0","volume":"223","author":"RY Calne","year":"1969","unstructured":"Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM, et al. Induction of immunological tolerance by porcine liver allografts. Nature. 1969;223:472\u20136.","journal-title":"Nature"},{"key":"6726_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00007890-198807000-00034","volume":"46","author":"N Kamada","year":"1988","unstructured":"Kamada N, Teramoto K, Baguerizo A, Ishikawa M, Sumimoto R, Ohkouchi Y. Cellular basis of transplantation tolerance induced by liver grafting in the rat. Extent of clonal deletion among thoracic duct lymphocytes, spleen, and lymph node cells. Transplantation. 1988;46:165\u20137.","journal-title":"Transplantation"},{"key":"6726_CR18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/292840a0","volume":"292","author":"N Kamada","year":"1981","unstructured":"Kamada N, Davies HS, Roser B. Reversal of transplantation immunity by liver grafting. Nature. 1981;292:840\u20132.","journal-title":"Nature"},{"key":"6726_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1615\/CritRevImmunol.v22.i1.30","volume":"22","author":"MJ Wick","year":"2002","unstructured":"Wick MJ, Leith\u00e4user F, Reimann J. The hepatic immune system. Crit Rev Immunol. 2002;22:47\u2013103.","journal-title":"Crit Rev Immunol"},{"key":"6726_CR20","first-page":"1845","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang M, Zhang C. The role of liver sinusoidal endothelial cells in cancer liver metastasis. Am J Cancer Res. 2021;11:1845\u201360.","journal-title":"Am J Cancer Res"},{"key":"6726_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1515\/hsz-2019-0283","volume":"401","author":"D H\u00e4ussinger","year":"2019","unstructured":"H\u00e4ussinger D, Kordes C. Space of Disse: a stem cell niche in the liver. Biol Chem. 2019;401:81\u201395.","journal-title":"Biol Chem"},{"key":"6726_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2009.07.011","volume":"34","author":"YH Oo","year":"2010","unstructured":"Oo YH, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun. 2010;34:45\u201354.","journal-title":"J Autoimmun"},{"key":"6726_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1872-034X.2007.00313.x","volume":"38","author":"T Watanabe","year":"2008","unstructured":"Watanabe T, Kudo M, Chiba T, Wakatsuki Y. Molecular mechanisms of portal vein tolerance. Hepatol Res. 2008;38:441\u20139.","journal-title":"Hepatol Res"},{"key":"6726_CR24","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.4049\/jimmunol.175.3.1643","volume":"175","author":"B John","year":"2005","unstructured":"John B, Crispe IN. TLR-4 regulates CD8+ T cell trapping in the liver. J Immunol. 2005;175:1643\u201350.","journal-title":"J Immunol"},{"key":"6726_CR25","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.4049\/jimmunol.169.5.2407","volume":"169","author":"K Klugewitz","year":"2002","unstructured":"Klugewitz K, Blumenthal-Barby F, Schrage A, Knolle PA, Hamann A, Crispe IN. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J Immunol. 2002;169:2407\u201313.","journal-title":"J Immunol"},{"key":"6726_CR26","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7520605","volume":"265","author":"Y Chen","year":"1994","unstructured":"Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994;265:1237\u201340.","journal-title":"Science"},{"key":"6726_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016817","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li C, Lu Y, Liu C, Yang W. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer. Front Immunol. 2022;13:1016817.","journal-title":"Front Immunol"},{"key":"6726_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1034\/j.1600-0528.2002.017412.x","volume":"174","author":"IN Crispe","year":"2000","unstructured":"Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev. 2000;174:47\u201362.","journal-title":"Immunol Rev"},{"key":"6726_CR29","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.4049\/jimmunol.163.6.3202","volume":"163","author":"WZ Mehal","year":"1999","unstructured":"Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol. 1999;163:3202\u201310.","journal-title":"J Immunol"},{"key":"6726_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/intimm\/6.4.533","volume":"6","author":"L Huang","year":"1994","unstructured":"Huang L, Sye K, Crispe IN. Proliferation and apoptosis of B220+CD4-CD8-TCR alpha beta intermediate T cells in the liver of normal adult mice: implication for lpr pathogenesis. Int Immunol. 1994;6:533\u201340.","journal-title":"Int Immunol"},{"key":"6726_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1084\/jem.183.2.431","volume":"183","author":"T Renno","year":"1996","unstructured":"Renno T, Hahne M, Tschopp J, MacDonald HR. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med. 1996;183:431\u20137.","journal-title":"J Exp Med"},{"key":"6726_CR32","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.4049\/jimmunol.136.11.4075","volume":"136","author":"WF Davidson","year":"1986","unstructured":"Davidson WF, Dumont FJ, Bedigian HG, Fowlkes BJ, Morse HC 3rd. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr\/lpr and C3H-gld\/gld mice. J Immunol. 1986;136:4075\u201384.","journal-title":"J Immunol"},{"key":"6726_CR33","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S1074-7613(94)80016-2","volume":"1","author":"L Huang","year":"1994","unstructured":"Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity. 1994;1:741\u20139.","journal-title":"Immunity"},{"key":"6726_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1046\/j.1440-1711.2002.01065.x","volume":"80","author":"S Park","year":"2002","unstructured":"Park S, Murray D, John B, Crispe IN. Biology and significance of T-cell apoptosis in the liver. Immunol cell Biol. 2002;80:74\u201383.","journal-title":"Immunol cell Biol"},{"key":"6726_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0167-5699(96)80906-6","volume":"17","author":"IN Crispe","year":"1996","unstructured":"Crispe IN, Mehal WZ. Strange brew: T cells in the liver. Immunol today. 1996;17:522\u20135.","journal-title":"Immunol today"},{"key":"6726_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/cmi.2011.47","volume":"9","author":"E Zhao","year":"2012","unstructured":"Zhao E, Xu H, Wang L, Kryczek I, Wu K, Hu Y, et al. Bone marrow and the control of immunity. Cell Mol Immunol. 2012;9:11\u201319.","journal-title":"Cell Mol Immunol"},{"key":"6726_CR37","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.4049\/jimmunol.166.9.5430","volume":"166","author":"P Bertolino","year":"2001","unstructured":"Bertolino P, Bowen DG, McCaughan GW, Fazekas de St Groth B. Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol. 2001;166:5430\u20138.","journal-title":"J Immunol"},{"key":"6726_CR38","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1172\/JCI119468","volume":"99","author":"J Wong","year":"1997","unstructured":"Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL, et al. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Investig. 1997;99:2782\u201390.","journal-title":"J Clin Investig"},{"key":"6726_CR39","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/hep.22795","volume":"49","author":"N von Oppen","year":"2009","unstructured":"von Oppen N, Schurich A, Hegenbarth S, Stabenow D, Tolba R, Weiskirchen R, et al. Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization. Hepatology. 2009;49:1664\u201372.","journal-title":"Hepatology"},{"key":"6726_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","volume":"36","author":"P Kubes","year":"2018","unstructured":"Kubes P, Jenne C. Immune responses in the liver. Annu Rev Immunol. 2018;36:247\u201377.","journal-title":"Annu Rev Immunol"},{"key":"6726_CR41","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1002\/eji.200636033","volume":"36","author":"M Berg","year":"2006","unstructured":"Berg M, Wingender G, Djandji D, Hegenbarth S, Momburg F, H\u00e4mmerling G, et al. Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance. Eur J Immunol. 2006;36:2960\u201370.","journal-title":"Eur J Immunol"},{"key":"6726_CR42","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/ni.2573","volume":"14","author":"LR Huang","year":"2013","unstructured":"Huang LR, Wohlleber D, Reisinger F, Jenne CN, Cheng RL, Abdullah Z, et al. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection. Nat Immunol. 2013;14:574\u201383.","journal-title":"Nat Immunol"},{"key":"6726_CR43","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/hep.22395","volume":"48","author":"Q You","year":"2008","unstructured":"You Q, Cheng L, Kedl RM, Ju C. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology. 2008;48:978\u201390.","journal-title":"Hepatology"},{"key":"6726_CR44","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4049\/jimmunol.162.3.1401","volume":"162","author":"PA Knolle","year":"1999","unstructured":"Knolle PA, Germann T, Treichel U, Uhrig A, Schmitt E, Hegenbarth S, et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol. 1999;162:1401\u20137.","journal-title":"J Immunol"},{"key":"6726_CR45","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3727\/096368913X666421","volume":"23","author":"G Sana","year":"2014","unstructured":"Sana G, Lombard C, Vosters O, Jazouli N, Andre F, Stephenne X, et al. Adult human hepatocytes promote CD4(+) T-cell hyporesponsiveness via interleukin-10-producing allogeneic dendritic cells. Cell Transplant. 2014;23:1127\u201342.","journal-title":"Cell Transplant"},{"key":"6726_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ. The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer. 2003;3:453\u20138.","journal-title":"Nat Rev Cancer"},{"key":"6726_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-022-00922-2","volume":"7","author":"H Zhou","year":"2022","unstructured":"Zhou H, Liu Z, Wang Y, Wen X, Amador EH, Yuan L, et al. Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduct Target Ther. 2022;7:70.","journal-title":"Signal Transduct Target Ther"},{"key":"6726_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","volume":"7","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Brodt P, Clavien PA, Muschel RJ, D\u2019Angelica MI, Endo I, et al. Liver metastases. Nat Rev Dis Prim. 2021;7:27.","journal-title":"Nat Rev Dis Prim"},{"key":"6726_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2009.08.008","volume":"34","author":"G Tiegs","year":"2010","unstructured":"Tiegs G, Lohse AW. Immune tolerance: what is unique about the liver. J Autoimmun. 2010;34:1\u20136.","journal-title":"J Autoimmun"},{"key":"6726_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-56553-3_1","volume":"161","author":"Z Kmie\u0107","year":"2001","unstructured":"Kmie\u0107 Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol. 2001;161:1\u2013151.","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"6726_CR51","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3748\/wjg.v13.i6.821","volume":"13","author":"F Braet","year":"2007","unstructured":"Braet F, Nagatsuma K, Saito M, Soon L, Wisse E, Matsuura T. The hepatic sinusoidal endothelial lining and colorectal liver metastases. World J Gastroenterol. 2007;13:821\u20135.","journal-title":"World J Gastroenterol"},{"key":"6726_CR52","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.pharep.2015.04.010","volume":"67","author":"E Maslak","year":"2015","unstructured":"Maslak E, Gregorius A, Chlopicki S. Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liver. Pharmacol Rep. 2015;67:689\u201394.","journal-title":"Pharmacol Rep"},{"key":"6726_CR53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.canlet.2009.04.029","volume":"284","author":"S Jansen","year":"2009","unstructured":"Jansen S, Andries M, Vekemans K, Vanbilloen H, Verbruggen A, Bollen M. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Lett. 2009;284:216\u201321.","journal-title":"Cancer Lett"},{"key":"6726_CR54","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1177\/1535370216658144","volume":"241","author":"AM Clark","year":"2016","unstructured":"Clark AM, Ma B, Taylor DL, Griffith L, Wells A. Liver metastases: microenvironments and ex-vivo models. Exp Biol Med. 2016;241:1639\u201352.","journal-title":"Exp Biol Med"},{"key":"6726_CR55","first-page":"5862","volume":"60","author":"HH Wang","year":"2000","unstructured":"Wang HH, McIntosh AR, Hasinoff BB, Rector ES, Ahmed N, Nance DM, et al. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res. 2000;60:5862\u20139.","journal-title":"Cancer Res"},{"key":"6726_CR56","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/01.shk.0000223130.87382.73","volume":"26","author":"H Yanagida","year":"2006","unstructured":"Yanagida H, Kaibori M, Yoshida H, Habara K, Yamada M, Kamiyama Y, et al. Hepatic ischemia\/reperfusion upregulates the susceptibility of hepatocytes to confer the induction of inducible nitric oxide synthase gene expression. Shock. 2006;26:162\u20138.","journal-title":"Shock"},{"key":"6726_CR57","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1002\/hep.25844","volume":"56","author":"B H\u00f6chst","year":"2012","unstructured":"H\u00f6chst B, Schildberg FA, B\u00f6ttcher J, Metzger C, Huss S, T\u00fcrler A, et al. Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice. Hepatology. 2012;56:1924\u201333.","journal-title":"Hepatology"},{"key":"6726_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","volume":"13","author":"MW Robinson","year":"2016","unstructured":"Robinson MW, Harmon C, O\u2019Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol. 2016;13:267\u201376.","journal-title":"Cell Mol Immunol"},{"key":"6726_CR59","doi-asserted-by":"crossref","unstructured":"Sun Y, Hu H, Liu Z, Xu J, Gao Y, Zhan X, et al. Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL\/4-1BB co-stimulation. J Immunother Cancer. 2023;11:e006481.","DOI":"10.1136\/jitc-2022-006481"},{"key":"6726_CR60","doi-asserted-by":"publisher","first-page":"e65599","DOI":"10.1371\/journal.pone.0065599","volume":"8","author":"ZK Ballas","year":"2013","unstructured":"Ballas ZK, Buchta CM, Rosean TR, Heusel JW, Shey MR. Role of NK cell subsets in organ-specific murine melanoma metastasis. PLoS ONE. 2013;8:e65599.","journal-title":"PLoS ONE"},{"key":"6726_CR61","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/ajt.13565","volume":"16","author":"C Harmon","year":"2016","unstructured":"Harmon C, Sanchez-Fueyo A, O\u2019Farrelly C, Houlihan DD. Natural Killer cells and liver transplantation: orchestrators of rejection or tolerance? Am J Transpl. 2016;16:751\u20137.","journal-title":"Am J Transpl"},{"key":"6726_CR62","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/j.1478-3231.2006.01342.x","volume":"26","author":"M Bilzer","year":"2006","unstructured":"Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int. 2006;26:1175\u201386.","journal-title":"Liver Int"},{"key":"6726_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.564768","volume":"11","author":"L Li","year":"2020","unstructured":"Li L, Zeng Z. Live imaging of innate and adaptive immune responses in the liver. Front Immunol. 2020;11:564768.","journal-title":"Front Immunol"},{"key":"6726_CR64","doi-asserted-by":"publisher","first-page":"14097","DOI":"10.1073\/pnas.1617903113","volume":"113","author":"Y Kimura","year":"2016","unstructured":"Kimura Y, Inoue A, Hangai S, Saijo S, Negishi H, Nishio J, et al. The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis. Proc Natl Acad Sci USA. 2016;113:14097\u2013102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6726_CR65","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1172\/JCI66776","volume":"124","author":"N G\u00fcl","year":"2014","unstructured":"G\u00fcl N, Babes L, Siegmund K, Korthouwer R, B\u00f6gels M, Braster R, et al. Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. J Clin Investig. 2014;124:812\u201323.","journal-title":"J Clin Investig"},{"key":"6726_CR66","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/jsre.1998.5532","volume":"82","author":"C Rushfeldt","year":"1999","unstructured":"Rushfeldt C, Sveinbj\u00f8rnsson B, Seljelid R, Smedsr\u00f8d B. Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense. J Surg Res. 1999;82:209\u201315.","journal-title":"J Surg Res"},{"key":"6726_CR67","doi-asserted-by":"publisher","first-page":"606","DOI":"10.4161\/cbt.24593","volume":"14","author":"SW Wen","year":"2013","unstructured":"Wen SW, Ager EI, Christophi C. Bimodal role of Kupffer cells during colorectal cancer liver metastasis. Cancer Biol Ther. 2013;14:606\u201313.","journal-title":"Cancer Biol Ther"},{"key":"6726_CR68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00535-017-1404-4","volume":"53","author":"L Shang","year":"2018","unstructured":"Shang L, Hosseini M, Liu X, Kisseleva T, Brenner DA. Human hepatic stellate cell isolation and characterization. J Gastroenterol. 2018;53:6\u201317.","journal-title":"J Gastroenterol"},{"key":"6726_CR69","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jss.2014.11.005","volume":"194","author":"C Eveno","year":"2015","unstructured":"Eveno C, Hainaud P, Rampanou A, Bonnin P, Bakhouche S, Dupuy E, et al. Proof of prometastatic niche induction by hepatic stellate cells. J Surg Res. 2015;194:496\u2013504.","journal-title":"J Surg Res"},{"key":"6726_CR70","doi-asserted-by":"publisher","first-page":"7573","DOI":"10.2147\/OTT.S214409","volume":"12","author":"WH Huang","year":"2019","unstructured":"Huang WH, Zhou MW, Zhu YF, Xiang JB, Li ZY, Wang ZH, et al. The role of hepatic stellate cells in promoting liver metastasis of colorectal carcinoma. OncoTargets Ther. 2019;12:7573\u201380.","journal-title":"OncoTargets Ther"},{"key":"6726_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01347-8","volume":"9","author":"KJ Wu","year":"2023","unstructured":"Wu KJ, Qian QF, Zhou JR, Sun DL, Duan YF, Zhu X, et al. Regulatory T cells (Tregs) in liver fibrosis. Cell Death Discov. 2023;9:53.","journal-title":"Cell Death Discov"},{"key":"6726_CR72","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820\u20137.","journal-title":"Nature"},{"key":"6726_CR73","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10555-013-9420-1","volume":"32","author":"J Sceneay","year":"2013","unstructured":"Sceneay J, Smyth MJ, M\u00f6ller A. The pre-metastatic niche: finding common ground. Cancer Metastasis Rev. 2013;32:449\u201364.","journal-title":"Cancer Metastasis Rev"},{"key":"6726_CR74","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu Y, Cao X. Characteristics and Significance of the Pre-metastatic Niche. Cancer Cell. 2016;30:668\u201381.","journal-title":"Cancer Cell"},{"key":"6726_CR75","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","volume":"10","author":"M Zheng","year":"2019","unstructured":"Zheng M, Tian Z. Liver-mediated adaptive immune tolerance. Front Immunol. 2019;10:2525.","journal-title":"Front Immunol"},{"key":"6726_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584458","volume":"11","author":"L Chen","year":"2020","unstructured":"Chen L, Zheng H, Yu X, Liu L, Li H, Zhu H, et al. Tumor-secreted GRP78 promotes the establishment of a pre-metastatic niche in the liver microenvironment. Front Immunol. 2020;11:584458.","journal-title":"Front Immunol"},{"key":"6726_CR77","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836\u201348.","journal-title":"Cancer Cell"},{"key":"6726_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07810-w","volume":"9","author":"Z Zeng","year":"2018","unstructured":"Zeng Z, Li Y, Pan Y, Lan X, Song F, Sun J, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun. 2018;9:5395.","journal-title":"Nat Commun"},{"key":"6726_CR79","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/BF02574475","volume":"9","author":"A Takeda","year":"2002","unstructured":"Takeda A, Stoeltzing O, Ahmad SA, Reinmuth N, Liu W, Parikh A, et al. Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol. 2002;9:610\u20136.","journal-title":"Ann Surg Oncol"},{"key":"6726_CR80","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ags3.12225","volume":"3","author":"T Murakami","year":"2019","unstructured":"Murakami T, Hiroshima Y, Matsuyama R, Homma Y, Hoffman RM, Endo I. Role of the tumor microenvironment in pancreatic cancer. Ann Gastroenterol Surg. 2019;3:130\u20137.","journal-title":"Ann Gastroenterol Surg"},{"key":"6726_CR81","doi-asserted-by":"crossref","unstructured":"Gumberger P, Bjornsson B, Sandstr\u00f6m P, Bojmar L, Zambirinis CP. The liver pre-metastatic niche in pancreatic cancer: a potential opportunity for intervention. Cancers. 2022;14:3028.","DOI":"10.3390\/cancers14123028"},{"key":"6726_CR82","doi-asserted-by":"crossref","unstructured":"Zhu JT. Helper cell differentiation, heterogeneity, and plasticity. Cold Spring Harb Perspect Biol. 2018;10:a030338.","DOI":"10.1101\/cshperspect.a030338"},{"key":"6726_CR83","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234:8509\u201321.","journal-title":"J Cell Physiol"},{"key":"6726_CR84","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00262-019-02426-5","volume":"68","author":"X Liu","year":"2019","unstructured":"Liu X, Li M, Wang X, Dang Z, Jiang Y, Wang X, et al. PD-1(+) TIGIT(+) CD8(+) T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma. Cancer Immunol Immunother. 2019;68:2041\u201354.","journal-title":"Cancer Immunol Immunother"},{"key":"6726_CR85","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ijc.29480","volume":"137","author":"L Sadegh","year":"2015","unstructured":"Sadegh L, Chen PW, Brown JR, Han Z, Niederkorn JY. NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases. Int J Cancer. 2015;137:1085\u201394.","journal-title":"Int J Cancer"},{"key":"6726_CR86","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3389\/fimmu.2018.01838","volume":"9","author":"M Terabe","year":"2018","unstructured":"Terabe M, Berzofsky JA. Tissue-specific roles of NKT cells in tumor immunity. Front Immunol. 2018;9:1838.","journal-title":"Front Immunol"},{"key":"6726_CR87","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12032-022-01888-5","volume":"40","author":"H Bayatipoor","year":"2022","unstructured":"Bayatipoor H, Mehdizadeh S, Jafarpour R, Shojaei Z, Pashangzadeh S, Motallebnezhad M. Role of NKT cells in cancer immunotherapy-from bench to bed. Med Oncol. 2022;40:29.","journal-title":"Med Oncol"},{"key":"6726_CR88","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/sj.bjc.6602022","volume":"91","author":"J Maher","year":"2004","unstructured":"Maher J, Davies ET. Targeting cytotoxic T lymphocytes for cancer immunotherapy. Br J Cancer. 2004;91:817\u201321.","journal-title":"Br J Cancer"},{"key":"6726_CR89","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fimmu.2019.00172","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Ding Y, Guo N, Wang S. MDSCs: key criminals of tumor pre-metastatic niche formation. Front Immunol. 2019;10:172.","journal-title":"Front Immunol"},{"key":"6726_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01714-0","volume":"22","author":"M Iglesias-Escudero","year":"2023","unstructured":"Iglesias-Escudero M, Arias-Gonz\u00e1lez N, Mart\u00ednez-C\u00e1ceres E. Regulatory cells and the effect of cancer immunotherapy. Mol cancer. 2023;22:26.","journal-title":"Mol cancer"},{"key":"6726_CR91","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1189\/jlb.0909607","volume":"87","author":"MK Connolly","year":"2010","unstructured":"Connolly MK, Mallen-St Clair J, Bedrosian AS, Malhotra A, Vera V, Ibrahim J, et al. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. J Leukoc Biol. 2010;87:713\u201325.","journal-title":"J Leukoc Biol"},{"key":"6726_CR92","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1609","volume":"13","author":"S Nagaraj","year":"2007","unstructured":"Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, Kang L, et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med. 2007;13:828\u201335.","journal-title":"Nat Med"},{"key":"6726_CR93","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1084\/jem.20101956","volume":"208","author":"B Molon","year":"2011","unstructured":"Molon B, Ugel S, Del Pozzo F, Soldani C, Zilio S, Avella D, et al. Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J Exp Med. 2011;208:1949\u201362.","journal-title":"J Exp Med"},{"key":"6726_CR94","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1158\/0008-5472.CAN-04-4505","volume":"65","author":"AH Zea","year":"2005","unstructured":"Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005;65:3044\u20138.","journal-title":"Cancer Res"},{"key":"6726_CR95","doi-asserted-by":"crossref","unstructured":"Lawal G, Xiao Y, Rahnemai-Azar AA, Tsilimigras DI, Kuang M, Bakopoulos A, et al. The immunology of hepatocellular carcinoma. Vaccines. 2021;9:1184.","DOI":"10.3390\/vaccines9101184"},{"key":"6726_CR96","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41419-019-1922-5","volume":"10","author":"Q Lin","year":"2019","unstructured":"Lin Q, Ren L, Jian M, Xu P, Li J, Zheng P, et al. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway. Cell Death Dis. 2019;10:693.","journal-title":"Cell Death Dis"},{"key":"6726_CR97","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3389\/fimmu.2020.00976","volume":"11","author":"N Karin","year":"2020","unstructured":"Karin N. CXCR3 ligands in cancer and autoimmunity, chemoattraction of effector T cells, and beyond. Front Immunol. 2020;11:976.","journal-title":"Front Immunol"},{"key":"6726_CR98","doi-asserted-by":"crossref","unstructured":"Oura K, Morishita A, Tani J, Masaki T. Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review. Int J Mol Sci. 2021;22:5801.","DOI":"10.3390\/ijms22115801"},{"key":"6726_CR99","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ncb3340","volume":"18","author":"SR Nielsen","year":"2016","unstructured":"Nielsen SR, Quaranta V, Linford A, Emeagi P, Rainer C, Santos A, et al. Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. Nat Cell Biol. 2016;18:549\u201360.","journal-title":"Nat Cell Biol"},{"key":"6726_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1160824","volume":"13","author":"S Beckinger","year":"2023","unstructured":"Beckinger S, Daunke T, Aldag L, Kr\u00fcger S, Heckl S, Wesch D, et al. Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma. Front Oncol. 2023;13:1160824.","journal-title":"Front Oncol"},{"key":"6726_CR101","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1158\/0008-5472.CAN-17-3876","volume":"78","author":"V Quaranta","year":"2018","unstructured":"Quaranta V, Rainer C, Nielsen SR, Raymant ML, Ahmed MS, Engle DD, et al. Macrophage-derived granulin drives resistance to immune checkpoint inhibition in metastatic pancreatic cancer. Cancer Res. 2018;78:4253\u201369.","journal-title":"Cancer Res"},{"key":"6726_CR102","doi-asserted-by":"publisher","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","volume":"115","author":"E Peranzoni","year":"2018","unstructured":"Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari-Mimoun C, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci USA. 2018;115:E4041\u2013e4050.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6726_CR103","doi-asserted-by":"publisher","first-page":"e108925","DOI":"10.1371\/journal.pone.0108925","volume":"9","author":"M Lundholm","year":"2014","unstructured":"Lundholm M, Schr\u00f6der M, Nagaeva O, Baranov V, Widmark A, Mincheva-Nilsson L, et al. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. PLoS ONE. 2014;9:e108925.","journal-title":"PLoS ONE"},{"key":"6726_CR104","doi-asserted-by":"crossref","unstructured":"Vautrot V, Bentayeb H, Causse S, Garrido C, Gobbo J. Tumor-derived exosomes: hidden players in PD-1\/PD-L1 resistance. Cancers. 2021;13:4537.","DOI":"10.3390\/cancers13184537"},{"key":"6726_CR105","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00262-021-03021-3","volume":"71","author":"X Chen","year":"2022","unstructured":"Chen X, Du Z, Huang M, Wang D, Fong WP, Liang J, et al. Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection. Cancer Immunol Immunother. 2022;71:661\u201374.","journal-title":"Cancer Immunol Immunother"},{"key":"6726_CR106","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21:504\u201316.","journal-title":"Cancer Cell"},{"key":"6726_CR107","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1053\/j.gastro.2018.04.001","volume":"155","author":"V Sethi","year":"2018","unstructured":"Sethi V, Kurtom S, Tarique M, Lavania S, Malchiodi Z, Hellmund L, et al. Gut microbiota promotes tumor growth in mice by modulating immune response. Gastroenterology. 2018;155:33\u201337.e36.","journal-title":"Gastroenterology"},{"key":"6726_CR108","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","volume":"17","author":"CA Brennan","year":"2019","unstructured":"Brennan CA, Garrett WS. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2019;17:156\u201366.","journal-title":"Nat Rev Microbiol"},{"key":"6726_CR109","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1101\/gr.122705.111","volume":"21","author":"S Minot","year":"2011","unstructured":"Minot S, Sinha R, Chen J, Li H, Keilbaugh SA, Wu GD, et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 2011;21:1616\u201325.","journal-title":"Genome Res"},{"key":"6726_CR110","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42:344\u201355.","journal-title":"Immunity"},{"key":"6726_CR111","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.4049\/jimmunol.1800627","volume":"201","author":"Z Jin","year":"2018","unstructured":"Jin Z, Lei L, Lin D, Liu Y, Song Y, Gong H, et al. IL-33 released in the liver inhibits tumor growth via promotion of CD4(+) and CD8(+) T cell responses in hepatocellular carcinoma. J Immunol. 2018;201:3770\u20139.","journal-title":"J Immunol"},{"key":"6726_CR112","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.7150\/ijbs.70137","volume":"18","author":"D Rong","year":"2022","unstructured":"Rong D, Sun G, Zheng Z, Liu L, Chen X, Wu F, et al. MGP promotes CD8(+) T cell exhaustion by activating the NF-\u03baB pathway leading to liver metastasis of colorectal cancer. Int J Biol Sci. 2022;18:2345\u201361.","journal-title":"Int J Biol Sci"},{"key":"6726_CR113","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/imr.12615","volume":"281","author":"A Malik","year":"2018","unstructured":"Malik A, Kanneganti TD. Function and regulation of IL-1\u03b1 in inflammatory diseases and cancer. Immunol Rev. 2018;281:124\u201337.","journal-title":"Immunol Rev"},{"key":"6726_CR114","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1369\/0022155421991634","volume":"69","author":"K Udagawa","year":"2021","unstructured":"Udagawa K, Niki Y, Kikuchi T, Fukuhara Y, Takeda Y, Miyamoto T, et al. Overexpression of Interleukin-1\u03b1 Suppresses Liver Metastasis of Lymphoma: Implications for Antitumor Effects of CD8+ T-cells. J Histochem Cytochem. 2021;69:245\u201355.","journal-title":"J Histochem Cytochem"},{"key":"6726_CR115","doi-asserted-by":"crossref","unstructured":"Ji D, Song C, Li Y, Xia J, Wu Y, Jia J, et al. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer. J Immunother Cancer. 2020;8:e000826.","DOI":"10.1136\/jitc-2020-000826"},{"key":"6726_CR116","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/nyas.13625","volume":"1417","author":"K Shitara","year":"2018","unstructured":"Shitara K, Nishikawa H. Regulatory T cells: a potential target in cancer immunotherapy. Ann N Y Acad Sci. 2018;1417:104\u201315.","journal-title":"Ann N Y Acad Sci"},{"key":"6726_CR117","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1038\/onc.2013.432","volume":"33","author":"AQ Butt","year":"2014","unstructured":"Butt AQ, Mills KH. Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines. Oncogene. 2014;33:4623\u201331.","journal-title":"Oncogene"},{"key":"6726_CR118","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490\u2013500.","journal-title":"Nat Rev Immunol"},{"key":"6726_CR119","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1158\/0008-5472.CAN-14-3173","volume":"75","author":"B Ham","year":"2015","unstructured":"Ham B, Wang N, D\u2019Costa Z, Fernandez MC, Bourdeau F, Auguste P, et al. TNF receptor-2 facilitates an immunosuppressive microenvironment in the liver to promote the colonization and growth of hepatic metastases. Cancer Res. 2015;75:5235\u201347.","journal-title":"Cancer Res"},{"key":"6726_CR120","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","volume":"66","author":"B Huang","year":"2006","unstructured":"Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J, et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006;66:1123\u201331.","journal-title":"Cancer Res"},{"key":"6726_CR121","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/annonc\/mdx278","volume":"28","author":"Q Wei","year":"2017","unstructured":"Wei Q, Ye Z, Zhong X, Li L, Wang C, Myers RE, et al. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis. Ann Oncol. 2017;28:2135\u201341.","journal-title":"Ann Oncol"},{"key":"6726_CR122","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1158\/0008-5472.CAN-20-3453","volume":"81","author":"C Zhang","year":"2021","unstructured":"Zhang C, Gao Y, Du C, Markowitz GJ, Fu J, Zhang Z, et al. Hepatitis B-Induced IL8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation. Cancer Res. 2021;81:2386\u201398.","journal-title":"Cancer Res"},{"key":"6726_CR123","doi-asserted-by":"crossref","unstructured":"Lee JC, Mehdizadeh S, Smith J, Young A, Mufazalov IA, Mowery CT, et al. Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Sci Immunol. 2020;5:eaba0759.","DOI":"10.1126\/sciimmunol.aba0759"},{"key":"6726_CR124","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.neo.2019.07.006","volume":"21","author":"E Fiegle","year":"2019","unstructured":"Fiegle E, Doleschel D, Koletnik S, Rix A, Weiskirchen R, Borkham-Kamphorst E, et al. Dual CTLA-4 and PD-L1 blockade inhibits tumor growth and liver metastasis in a highly aggressive orthotopic mouse model of colon cancer. Neoplasia. 2019;21:932\u201344.","journal-title":"Neoplasia"},{"key":"6726_CR125","doi-asserted-by":"crossref","unstructured":"Korbecki J, Bajdak-Rusinek K, Kupnicka P, Kapczuk P, Simi\u0144ska D, Chlubek D et al. The role of CXCL16 in the pathogenesis of cancer and other diseases. Int J Mol Sci. 2021;22:3490.","DOI":"10.3390\/ijms22073490"},{"key":"6726_CR126","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","volume":"36","author":"N Arenas-Ramirez","year":"2015","unstructured":"Arenas-Ramirez N, Woytschak J, Boyman O. Interleukin-2: biology, design and application. Trends Immunol. 2015;36:763\u201377.","journal-title":"Trends Immunol"},{"key":"6726_CR127","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.2337\/db14-1322","volume":"64","author":"A Yu","year":"2015","unstructured":"Yu A, Snowhite I, Vendrame F, Rosenzwajg M, Klatzmann D, Pugliese A, et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes. 2015;64:2172\u201383.","journal-title":"Diabetes"},{"key":"6726_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844931","volume":"13","author":"J Bai","year":"2022","unstructured":"Bai J, Ding B, Li H. Targeting TNFR2 in cancer: all roads lead to Rome. Front Immunol. 2022;13:844931.","journal-title":"Front Immunol"},{"key":"6726_CR129","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.4161\/onci.21566","volume":"1","author":"E Schouppe","year":"2012","unstructured":"Schouppe E, De Baetselier P, Van Ginderachter JA, Sarukhan A. Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations. Oncoimmunology. 2012;1:1135\u201345.","journal-title":"Oncoimmunology"},{"key":"6726_CR130","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549\u201355.","journal-title":"Trends Immunol"},{"key":"6726_CR131","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2015.00212","volume":"6","author":"CD Mills","year":"2015","unstructured":"Mills CD. Anatomy of a discovery: m1 and m2 macrophages. Front Immunol. 2015;6:212.","journal-title":"Front Immunol"},{"key":"6726_CR132","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/hep.27793","volume":"62","author":"F Heymann","year":"2015","unstructured":"Heymann F, Peusquens J, Ludwig-Portugall I, Kohlhepp M, Ergen C, Niemietz P, et al. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology. 2015;62:279\u201391.","journal-title":"Hepatology"},{"key":"6726_CR133","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2023.12.015","volume":"80","author":"AM Shiri","year":"2024","unstructured":"Shiri AM, Zhang T, Bedke T, Zazara DE, Zhao L, L\u00fccke J, et al. IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction. J Hepatol. 2024;80:634\u201344.","journal-title":"J Hepatol"},{"key":"6726_CR134","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1158\/0008-5472.CAN-09-1882","volume":"70","author":"PY Pan","year":"2010","unstructured":"Pan PY, Ma G, Weber KJ, Ozao-Choy J, Wang G, Yin B, et al. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 2010;70:99\u2013108.","journal-title":"Cancer Res"},{"key":"6726_CR135","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/02841860600604611","volume":"45","author":"PJ Wers\u00e4ll","year":"2006","unstructured":"Wers\u00e4ll PJ, Blomgren H, Pisa P, Lax I, K\u00e4lkner KM, Svedman C. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol. 2006;45:493\u20137.","journal-title":"Acta Oncol"},{"key":"6726_CR136","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3389\/fimmu.2019.02048","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Tian Z. HBV-induced immune imbalance in the development of HCC. Front Immunol. 2019;10:2048.","journal-title":"Front Immunol"},{"key":"6726_CR137","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","volume":"39","author":"C Dong","year":"2021","unstructured":"Dong C. Cytokine regulation and function in T cells. Annu Rev Immunol. 2021;39:51\u201376.","journal-title":"Annu Rev Immunol"},{"key":"6726_CR138","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","volume":"164","author":"AK Palucka","year":"2016","unstructured":"Palucka AK, Coussens LM. The basis of oncoimmunology. Cell. 2016;164:1233\u201347.","journal-title":"Cell"},{"key":"6726_CR139","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.vetpar.2017.03.022","volume":"238","author":"IL Pacheco","year":"2017","unstructured":"Pacheco IL, Abril N, Morales-Prieto N, Bautista MJ, Zafra R, Escamilla A, et al. Th1\/Th2 balance in the liver and hepatic lymph nodes of vaccinated and unvaccinated sheep during acute stages of infection with Fasciola hepatica. Vet Parasitol. 2017;238:61\u201365.","journal-title":"Vet Parasitol"},{"key":"6726_CR140","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20101876","volume":"208","author":"L De Monte","year":"2011","unstructured":"De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H, et al. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med. 2011;208:469\u201378.","journal-title":"J Exp Med"},{"key":"6726_CR141","doi-asserted-by":"crossref","unstructured":"Kroemer M, Turco C, Spehner L, Viot J, Idir\u00e8ne I, Bouard A, et al. Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases. J Immunother Cancer. 2020;8:e001478.","DOI":"10.1136\/jitc-2020-001478"},{"key":"6726_CR142","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/hep.20795","volume":"42","author":"SC Katz","year":"2005","unstructured":"Katz SC, Pillarisetty VG, Bleier JI, Kingham TP, Chaudhry UI, Shah AB, et al. Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors. Hepatology. 2005;42:293\u2013300.","journal-title":"Hepatology"},{"key":"6726_CR143","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","volume":"16","author":"DG DeNardo","year":"2009","unstructured":"DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 2009;16:91\u2013102.","journal-title":"Cancer Cell"},{"key":"6726_CR144","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3892\/ol.2016.4854","volume":"12","author":"X Xu","year":"2016","unstructured":"Xu X, Wang R, Su Q, Huang H, Zhou P, Luan J, et al. Expression of Th1- Th2- and Th17-associated cytokines in laryngeal carcinoma. Oncol Lett. 2016;12:1941\u20138.","journal-title":"Oncol Lett"},{"key":"6726_CR145","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-065X.2008.00607.x","volume":"222","author":"P Allavena","year":"2008","unstructured":"Allavena P, Sica A, Garlanda C, Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev. 2008;222:155\u201361.","journal-title":"Immunol Rev"},{"key":"6726_CR146","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/carcin\/bgh146","volume":"25","author":"T Hagemann","year":"2004","unstructured":"Hagemann T, Robinson SC, Schulz M, Tr\u00fcmper L, Balkwill FR, Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis. 2004;25:1543\u20139.","journal-title":"Carcinogenesis"},{"key":"6726_CR147","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1245\/s10434-008-9971-5","volume":"15","author":"P Wagner","year":"2008","unstructured":"Wagner P, Koch M, Nummer D, Palm S, Galindo L, Autenrieth D, et al. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer. Ann Surg Oncol. 2008;15:2310\u20137.","journal-title":"Ann Surg Oncol"},{"key":"6726_CR148","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/hep.32009","volume":"74","author":"H Sun","year":"2021","unstructured":"Sun H, Meng Q, Shi C, Yang H, Li X, Wu S, et al. Hypoxia-inducible exosomes facilitate liver-tropic premetastatic niche in colorectal cancer. Hepatology. 2021;74:2633\u201351.","journal-title":"Hepatology"},{"key":"6726_CR149","first-page":"877","volume":"116","author":"M Oka","year":"1994","unstructured":"Oka M, Hazama S, Suzuki M, Wang F, Shimoda K, Iizuka N, et al. Depression of cytotoxicity of nonparenchymal cells in the liver after surgery. Surgery. 1994;116:877\u201382.","journal-title":"Surgery"},{"key":"6726_CR150","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/00000542-200703000-00014","volume":"106","author":"H Wada","year":"2007","unstructured":"Wada H, Seki S, Takahashi T, Kawarabayashi N, Higuchi H, Habu Y, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1\/TH2 cytokine balance. Anesthesiology. 2007;106:499\u2013506.","journal-title":"Anesthesiology"},{"key":"6726_CR151","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tips.2014.07.006","volume":"35","author":"J Yang","year":"2014","unstructured":"Yang J, Sundrud MS, Skepner J, Yamagata T. Targeting Th17 cells in autoimmune diseases. Trends Pharmacol Sci. 2014;35:493\u2013500.","journal-title":"Trends Pharmacol Sci"},{"key":"6726_CR152","first-page":"2963","volume":"17","author":"H Mou","year":"2019","unstructured":"Mou H, Wu S, Zhao G, Wang J. Changes of Th17\/Treg ratio in the transition of chronic hepatitis B to liver cirrhosis and correlations with liver function and inflammation. Exp Ther Med. 2019;17:2963\u20138.","journal-title":"Exp Ther Med"},{"key":"6726_CR153","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature"},{"key":"6726_CR154","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","volume":"15","author":"HM Knochelmann","year":"2018","unstructured":"Knochelmann HM, Dwyer CJ, Bailey SR, Amaya SM, Elston DM, Mazza-McCrann JM, et al. When worlds collide: Th17 and Treg cells in cancer and autoimmunity. Cell Mol Immunol. 2018;15:458\u201369.","journal-title":"Cell Mol Immunol"},{"key":"6726_CR155","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1084\/jem.20090207","volume":"206","author":"L Wang","year":"2009","unstructured":"Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med. 2009;206:1457\u201364.","journal-title":"J Exp Med"},{"key":"6726_CR156","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41392-022-00895-2","volume":"7","author":"R Sun","year":"2022","unstructured":"Sun R, Zhang PP, Weng XQ, Gao XD, Huang CX, Wang L, et al. Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40\/OX40L-mediated interaction with Th17 cells. Signal Transduct Target Ther. 2022;7:80.","journal-title":"Signal Transduct Target Ther"},{"key":"6726_CR157","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.4049\/jimmunol.0902574","volume":"184","author":"D He","year":"2010","unstructured":"He D, Li H, Yusuf N, Elmets CA, Li J, Mountz JD, et al. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J Immunol. 2010;184:2281\u20138.","journal-title":"J Immunol"},{"key":"6726_CR158","doi-asserted-by":"publisher","first-page":"e21816","DOI":"10.1371\/journal.pone.0021816","volume":"6","author":"J Li","year":"2011","unstructured":"Li J, Lau GK, Chen L, Dong SS, Lan HY, Huang XR, et al. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS ONE. 2011;6:e21816.","journal-title":"PLoS ONE"},{"key":"6726_CR159","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10456-018-9658-x","volume":"22","author":"NJ Protopsaltis","year":"2019","unstructured":"Protopsaltis NJ, Liang W, Nudleman E, Ferrara N. Interleukin-22 promotes tumor angiogenesis. Angiogenesis. 2019;22:311\u201323.","journal-title":"Angiogenesis"},{"key":"6726_CR160","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2269634","volume":"12","author":"T Zhang","year":"2023","unstructured":"Zhang T, Wahib R, Zazara DE, L\u00fccke J, Shiri AM, Kempski J, et al. CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis. Oncoimmunology. 2023;12:2269634.","journal-title":"Oncoimmunology"},{"key":"6726_CR161","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3892\/or.2012.2185","volume":"29","author":"JY Kee","year":"2013","unstructured":"Kee JY, Ito A, Hojo S, Hashimoto I, Igarashi Y, Tsukada K, et al. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model. Oncol Rep. 2013;29:975\u201382.","journal-title":"Oncol Rep"},{"key":"6726_CR162","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/82698","volume":"1","author":"MJ Smyth","year":"2000","unstructured":"Smyth MJ, Godfrey DI. NKT cells and tumor immunity\u2013a double-edged sword. Nat Immunol. 2000;1:459\u201360.","journal-title":"Nat Immunol"},{"key":"6726_CR163","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.4049\/jimmunol.180.6.3627","volume":"180","author":"JA Berzofsky","year":"2008","unstructured":"Berzofsky JA, Terabe M. NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis. J Immunol (Baltim, Md: 1950). 2008;180:3627\u201335.","journal-title":"J Immunol (Baltim, Md: 1950)"},{"key":"6726_CR164","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/2326-6066.CIR-21-0445","volume":"10","author":"L Babes","year":"2022","unstructured":"Babes L, Shim R, Kubes P. Imaging \u03b1-GalCer-activated iNKT cells in a hepatic metastatic environment. Cancer Immunol Res. 2022;10:12\u201325.","journal-title":"Cancer Immunol Res"},{"key":"6726_CR165","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s005950200027","volume":"32","author":"T Kobayashi","year":"2002","unstructured":"Kobayashi T, Shiiba K, Satoh M, Hashimoto W, Mizoi T, Matsuno S, et al. Interleukin-12 administration is more effective for preventing metastasis than for inhibiting primary established tumors in a murine model of spontaneous hepatic metastasis. Surg Today. 2002;32:236\u201342.","journal-title":"Surg Today"},{"key":"6726_CR166","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1084\/jem.189.7.1121","volume":"189","author":"H Kitamura","year":"1999","unstructured":"Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, et al. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med. 1999;189:1121\u20138.","journal-title":"J Exp Med"},{"key":"6726_CR167","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/82771","volume":"1","author":"M Terabe","year":"2000","unstructured":"Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol. 2000;1:515\u201320.","journal-title":"Nat Immunol"},{"key":"6726_CR168","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1084\/jem.20022227","volume":"198","author":"M Terabe","year":"2003","unstructured":"Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, et al. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med. 2003;198:1741\u201352.","journal-title":"J Exp Med"},{"key":"6726_CR169","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.18632\/aging.203914","volume":"14","author":"H Yin","year":"2022","unstructured":"Yin H, Miao Z, Wang L, Su B, Liu C, Jin Y, et al. Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota. Aging. 2022;14:1941\u201358.","journal-title":"Aging"},{"key":"6726_CR170","doi-asserted-by":"crossref","unstructured":"Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360:eaan5931.","DOI":"10.1126\/science.aan5931"},{"key":"6726_CR171","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10565-020-09518-4","volume":"36","author":"X Ma","year":"2020","unstructured":"Ma X, Zhou Z, Zhang X, Fan M, Hong Y, Feng Y, et al. Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice. Cell Biol Toxicol. 2020;36:509\u201315.","journal-title":"Cell Biol Toxicol"},{"key":"6726_CR172","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.4049\/jimmunol.0803520","volume":"183","author":"R Cullen","year":"2009","unstructured":"Cullen R, Germanov E, Shimaoka T, Johnston B. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation. J Immunol. 2009;183:5807\u201315.","journal-title":"J Immunol"},{"key":"6726_CR173","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jlb.64.1.25","volume":"64","author":"MJ Fenton","year":"1998","unstructured":"Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. J Leukoc Biol. 1998;64:25\u201332.","journal-title":"J Leukoc Biol"},{"key":"6726_CR174","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000475931","volume":"9","author":"M Kinoshita","year":"2017","unstructured":"Kinoshita M, Miyazaki H, Nakashima H, Nakashima M, Nishikawa M, Ishikiriyama T, et al. In vivo lipopolysaccharide tolerance recruits CD11b+ macrophages to the liver with enhanced bactericidal activity and low tumor necrosis factor-releasing capability, resulting in drastic resistance to lethal septicemia. J Innate Immun. 2017;9:493\u2013510.","journal-title":"J Innate Immun"},{"key":"6726_CR175","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00011-014-0740-6","volume":"63","author":"R Chang","year":"2014","unstructured":"Chang R, Wang Y, Chang J, Wen L, Jiang Z, Yang T, et al. LPS preconditioning ameliorates intestinal injury in a rat model of hemorrhagic shock. Inflamm Res. 2014;63:675\u201382.","journal-title":"Inflamm Res"},{"key":"6726_CR176","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/jgh.15375","volume":"36","author":"M Nishikawa","year":"2021","unstructured":"Nishikawa M, Kinoshita M, Morimoto Y, Ishikiriyama T, Nakashima M, Nakashima H, et al. Lipopolysaccharide preconditioning reduces liver metastasis of Colon26 cells by enhancing antitumor activity of natural killer cells and natural killer T cells in murine liver. J Gastroenterol Hepatol. 2021;36:1889\u201398.","journal-title":"J Gastroenterol Hepatol"},{"key":"6726_CR177","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/hep.32585","volume":"77","author":"X Zeng","year":"2023","unstructured":"Zeng X, Liao G, Li S, Liu H, Zhao X, Li S, et al. Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation. Hepatology. 2023;77:1122\u201338.","journal-title":"Hepatology"},{"key":"6726_CR178","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1148\/radiol.12111851","volume":"265","author":"L Solbiati","year":"2012","unstructured":"Solbiati L, Ahmed M, Cova L, Ierace T, Brioschi M, Goldberg SN. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265:958\u201368.","journal-title":"Radiology"},{"key":"6726_CR179","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrc3672","volume":"14","author":"KF Chu","year":"2014","unstructured":"Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199\u2013208.","journal-title":"Nat Rev Cancer"},{"key":"6726_CR180","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1007\/s00330-019-06189-6","volume":"29","author":"Y Minami","year":"2019","unstructured":"Minami Y, Nishida N, Kudo M. Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy. Eur Radio. 2019;29:5045\u201351.","journal-title":"Eur Radio"},{"key":"6726_CR181","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1158\/1078-0432.CCR-15-1352","volume":"22","author":"L Shi","year":"2016","unstructured":"Shi L, Chen L, Wu C, Zhu Y, Xu B, Zheng X, et al. PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor. Clin Cancer Res. 2016;22:1173\u201384.","journal-title":"Clin Cancer Res"},{"key":"6726_CR182","doi-asserted-by":"crossref","unstructured":"Shankara Narayanan JS, Hayashi T, Erdem S, McArdle S, Tiriac H, Ray P, et al. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model. J Immunother Cancer. 2023;11:e006133.","DOI":"10.1136\/jitc-2022-006133"},{"key":"6726_CR183","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1055\/s-2007-991536","volume":"33","author":"A Falanga","year":"2007","unstructured":"Falanga A, Marchetti M. Heparin in tumor progression and metastatic dissemination. Semin Thromb Hemost. 2007;33:688\u201394.","journal-title":"Semin Thromb Hemost"},{"key":"6726_CR184","doi-asserted-by":"crossref","unstructured":"Quan Y, He J, Zou Q, Zhang L, Sun Q, Huang H, et al. Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer. J Immunother Cancer. 2023;11:e007080.","DOI":"10.1136\/jitc-2023-007080"},{"key":"6726_CR185","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.3892\/or.2017.5531","volume":"37","author":"MH Al Bandar","year":"2017","unstructured":"Al Bandar MH, Kim NK. Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review). Oncol Rep. 2017;37:2553\u201364.","journal-title":"Oncol Rep"},{"key":"6726_CR186","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13046-023-02804-z","volume":"42","author":"Y Ma","year":"2023","unstructured":"Ma Y, Guo C, Wang X, Wei X, Ma J. Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape. J Exp Clin Cancer Res. 2023;42:237.","journal-title":"J Exp Clin Cancer Res"},{"key":"6726_CR187","doi-asserted-by":"crossref","unstructured":"Ho TTB, Nasti A, Seki A, Komura T, Inui H, Kozaka T, et al. Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis. J Immunother Cancer. 2020;8:e001367.","DOI":"10.1136\/jitc-2020-001367"},{"key":"6726_CR188","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88.","journal-title":"Cell Death Dis"},{"key":"6726_CR189","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","volume":"72","author":"C Conche","year":"2023","unstructured":"Conche C, Finkelmeier F, Pe\u0161i\u0107 M, Nicolas AM, B\u00f6ttger TW, Kennel KB, et al. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut. 2023;72:1774\u201382.","journal-title":"Gut"},{"key":"6726_CR190","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMra0912273","volume":"363","author":"BY Kim","year":"2010","unstructured":"Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010;363:2434\u201343.","journal-title":"N Engl J Med"},{"key":"6726_CR191","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2174\/1566523214666141224095610","volume":"15","author":"S Thakral","year":"2015","unstructured":"Thakral S, Ghoshal K. miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. Curr Gene Ther. 2015;15:142\u201350.","journal-title":"Curr Gene Ther"},{"key":"6726_CR192","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/hep.22806","volume":"49","author":"WC Tsai","year":"2009","unstructured":"Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009;49:1571\u201382.","journal-title":"Hepatology"},{"key":"6726_CR193","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcb.20982","volume":"99","author":"H Kutay","year":"2006","unstructured":"Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem. 2006;99:671\u20138.","journal-title":"J Cell Biochem"},{"key":"6726_CR194","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1158\/0008-5472.CAN-21-2269","volume":"82","author":"H Sendi","year":"2022","unstructured":"Sendi H, Yazdimamaghani M, Hu M, Sultanpuram N, Wang J, Moody AS, et al. Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis. Cancer Res. 2022;82:105\u201313.","journal-title":"Cancer Res"},{"key":"6726_CR195","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jconrel.2024.03.052","volume":"369","author":"D Ding","year":"2024","unstructured":"Ding D, Liang R, Li T, Lan T, Li Y, Huang S, et al. Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer. J Control Release. 2024;369:309\u201324.","journal-title":"J Control Release"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06726-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06726-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06726-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T03:02:45Z","timestamp":1715828565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06726-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":195,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["6726"],"URL":"https:\/\/doi.org\/10.1038\/s41419-024-06726-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}